Notícias Eulerpool Knight Therapeutics

Knight Therapeutics Notícias de ações

Knight Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Knight Therapeutics nós reunimos aqui.

• 14 de novembro ·

  Yahoo
  Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
• 9 de novembro ·

  SeekingAlpha
  Knight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call Transcript
• 8 de novembro ·

  Yahoo
  Knight Therapeutics (TSE:GUD) investors are sitting on a loss of 33% if they invested five years ago
• 8 de novembro ·

  Yahoo
  Knight Therapeutics Inc (KHTRF) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Margin ...
• 7 de novembro ·

  Yahoo
  Knight Therapeutics Reports Third Quarter 2024
• 31 de outubro ·

  Yahoo
  Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call
• 15 de outubro ·

  Yahoo
  Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico
• 9 de outubro ·

  Yahoo
  Knight Therapeutics Inc (KHTRF) Q2 2024 Earnings Call Highlights: Record Revenues and Strategic ...
• 27 de setembro ·

  Yahoo
  Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
• 9 de setembro ·

  Yahoo
  3 High Insider Owned TSX Growth Companies With Earnings Up To 66%